Key Insights

Highlights

Treatment Research

3 treatments under study, led by Hpv Mistics Provider Level

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1
Active Not Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Hpv Mistics Provider Level1
  • Hpv Mistics Parent Level1
  • Hpv Mistics Hpv Vaccine Champion Level1

Active Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1
  • Assiut University1
  • Health Choice Network1
  • Florida Department of Health1

Top Investigators

Activity Timeline